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Dr Sary F. Aranki (Boston, Mass). I have nothing to disclose.
This is the fourth study in this meeting that addresses the theme of
more arterial revascularization and the use of bilateral internal
mammary arteries in patients undergoing CABG surgery.
Dr Kim and his colleagues just presented the only study that was
a randomized controlled study. They previously published
graft patency rates at 1 day. Now, they present the 1-yearThe Journal of Thoracic and Caangiographic data for 98% of their randomized patients. In addi-
tion, they also report on the 1- and 4-year clinical outcomes.
Their major findings were that if the SV graft is used as a Y-
composite graft from the left internal mammary artery (LIMA),
it is as good, or noninferior, as a free RIMA graft deployed in
the same fashion regarding the 1-year patency and 1- and 4-year
outcomes. Therefore, I interpret these results to indicate that a
SV graft from the LIMA is as good as a bilateral internal mammary
artery. These results are too good to be true. However, I congratu-
late Dr Kim and his team on a study well done and a well-written
and clear report.
Dr Kim, I am very nervous every time I use the LIMA as the sole
source of coronary blood supply in patients with 3-vessel disease. I
believe that the LIMA is so valuable that it should be used prefer-
entially for the left anterior descending artery; no sharing. Howev-
er, the results speak for themselves. I have the following questions
for you.
Question 1. How do you determine preoperatively and intrao-
peratively whether the LIMA is going to have adequate blood
flow to sustain the entire coronary circulation?
Dr Kim. Thank you, Sary, for your nice comments and good
questions. We have performed CABG using a Y-composite graft
based on the left ITA single inflow in most of our patients
since mid-2000. Although a concern exists that construction of a
Y-composite graft based on the left ITA single inflow may not
supply sufficient blood flow to a wider area of myocardium, we
are not able to decide it preoperatively or intraoperatively.
In our previous study, we compared the degree and time course
of myocardial perfusion improvement between the bilateral in situ
ITAs group and the Y-composite group using the myocardial single
photon emission computed tomography performed preoperatively
and at 3 months and 1 year after surgery. We published the data in
the Journal of Thoracic and Cardiovascular Surgery in 2007. Our
data demonstrated that revascularization with a Y-composite graft
or bilateral in situ ITAs graft exhibited a complete recovery of
stress perfusion and a similar pattern of reversibility improvement
until 1 year after surgery. Therefore, we suggest that revasculariza-
tion using a Y-composite graft based on the left ITA single inflow
might be sufficient to supply the whole heart.
Dr Aranki. Okay. My second question. There were 245 distal
anastomoses with the vein graft versus 204 in the RITA group.
Was this difference significant and did those patients have more
complete revascularization?
Dr Kim. As I presented in my slides, the average length of the
harvested RITA was shorter than that of the SV harvested from a
lower leg. Therefore, the average number of distal anastomoses us-
ing the RITAwas smaller than that of distal anastomoses using the
SV. When the length of the Y-composite graft was not sufficient for
complete revascularization, an additional SV segment was harvested
to lengthen the conduit. In the RITA group, an additional SV
segment was harvested in 40 patients and connected to the RITA
for complete revascularization. Therefore, the average number of
distal anastomoses per patient was similar between the 2 groups.
DrAranki. The next question, and the last. Currently, only 20%
of coronary bypass operations are done as OPCAB in the United
States. What would your advice be to surgeons who perform on-
pump CABG? Do you advise them to do a Y-vein graft to the
LIMA in those patients, too, or just for OPCAB patients?rdiovascular Surgery c Volume 148, Number 3 907
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DDrKim.My answer is yes. We also performed on-pump CABG
using the SV composite graft. I would like to recommend using the
SV composite graft for both off-pump and on-pump CABGs.
There are several advantages using the SV composite graft over
the aortocoronary bypass graft.
First, the SV conduit may be exposed to less circulatory stress
than a conduit anastomosed to the ascending aorta. Second, the
SV conduit anastomosed to the left ITA is exposed continuously
to endothelium-protective substances such as nitric oxide pro-
duced from the ITA. Third, complications such as embolic stroke
and aortic dissection could be reduced by avoiding additional
aortic clamping for proximal anastomosis during on-pump CABG.
Dr Aranki. Thank you, Dr Kim.
Dr John D. Puskas (New York, NY). No disclosures. Dr Kim, I
am impressed with your study. I congratulate you and your col-
leagues for excellent surgical results and the rigor to embark and
complete a prospective randomized trial; I know how difficult that is.
I was also impressed by your answers and your thoughts of why
the vein might actually do so well coming off the ITA. There might
be another possible explanation. I noticed that you chose the lower
leg vein, which would naturally be smaller in caliber than the upper
thigh vein and would match your ITA somewhat better. You also
harvested that vein using an open technique with minimal manipu-
lation. I think it is very important, in general, how we harvest our
conduits and that they be harvested in an atraumatic way; whether
opened or closed, they should be atraumatically harvested.
Do you think that might be 1 reason in this short follow-up, the
vein was performing as well as a RITA? Is it the harvest technique
you used for the vein that improves its function and makes it
perform similar to an RITA?
Dr Kim. Whenever harvesting the SV, it is very important to
prevent inadvertent SV injury. It might be one of the factors for
our improving patency results with SV composite grafting.
Dr Puskas.Doyou dilate the veins under pressurewith a syringe?
Dr Kim.No, we do not manually dilate the SVafter harvesting.
The SV harvest was initiated after systemic heparinization. It was
performed using an atraumatic, open technique, so that manipula-
tion was limited to the perivascular tissue, leaving the surrounding
adipose tissue in place. Immediately after the SV was harvested, it
was used to construct a Y-composite graft.908 The Journal of Thoracic and Cardiovascular SurgDr Puskas. I agree with all of those points. How do you
construct your anastomosis between the lower leg atraumatically
harvested SV and the ITA? Do you make a T or a Y?
Dr Kim. I always perform a Y-anastomosis using an 8-0 poly-
propylene continuous suture technique.
Dr Puskas. Congratulations on your study.
Dr Brian F. Buxton (Melbourne, Australia). I think this is an
excellent study, and I do not know of any or very few other ran-
domized trials comparing the RITA with the SV, with exception
of only one other.
Now the question is, when I first had the privilege of being
a primary discussant with your study, I think it was 2 years
ago, I wondered why at the time you chose to use an off-
pump technique rather than conventional anastomoses from
the aorta. However, having looked at the brilliant results that
you have had with Y-grafting and off-pump surgery, I now fully
understand.
The question I really want to ask you is, what are the power cal-
culations? Is 112 patients in each group enough to give you a long-
term result?
Dr Kim. We have to extend our patency study up to several
years after surgery and analyze the long-term clinical outcomes.
Dr A. Pieter Kappetein (Rotterdam, The Netherlands). The
other part of the question was did you perform a sample size
calculation?
Dr Kim. The study was designed to have 80% power to detect
1-year patency rates of 93% in the SV versus 95% in the RITA
grafts, with a noninferiority margin of8%. A total of 97 patients
were required in each group.
Allowing for a 3% withdrawal in the perioperative period and a
10% withdrawal during 1 year of follow-up, it was calculated that
recruitment of 112 patients was needed in each group.
Dr Buxton. An inferiority calculation is somewhat difficult,
and this is going to test the statistics of that calculation.
But the other issue is, having been down this road before, look-
ing at the long-term results after changing a technique in coronary
artery bypass surgery, I am still struggling after 10 years, because
the changes are very slow to evolve. Thus, I think 1 year is going to
be the first of a number of study periods, possibly even as long as 5
or 10 years.ery c September 2014
